XML 55 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment information (Tables)
 9 Months Ended
Apr. 30, 2017
Segment Reporting [Abstract]  
Reportable Segment Information

The tables below present information about our reportable segments:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

April 30,

 

 

April 30,

 

(in millions)

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Product revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Imaging

 

$

68.2

 

 

$

71.9

 

 

$

205.9

 

 

$

208.7

 

Ultrasound

 

 

34.8

 

 

 

36.8

 

 

 

110.7

 

 

 

115.9

 

Security and Detection

 

 

17.8

 

 

 

17.6

 

 

 

54.8

 

 

 

41.8

 

Total product revenue

 

$

120.8

 

 

$

126.3

 

 

$

371.4

 

 

$

366.4

 

Engineering revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Imaging

 

$

1.3

 

 

$

0.9

 

 

$

3.1

 

 

$

2.6

 

Ultrasound

 

 

-

 

 

 

0.8

 

 

 

0.2

 

 

 

1.7

 

Security and Detection

 

 

0.1

 

 

 

(0.1

)

 

 

0.1

 

 

 

0.1

 

Total engineering revenue

 

$

1.4

 

 

$

1.6

 

 

$

3.4

 

 

$

4.4

 

Net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Imaging

 

$

69.5

 

 

$

72.9

 

 

$

209.0

 

 

$

211.3

 

Ultrasound

 

 

34.8

 

 

 

37.6

 

 

 

110.9

 

 

 

117.6

 

Security and Detection

 

 

17.9

 

 

 

17.5

 

 

 

54.9

 

 

 

41.9

 

Total net revenue

 

$

122.2

 

 

$

128.0

 

 

$

374.8

 

 

$

370.8

 

Income (loss) from operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Imaging (A)

 

$

12.2

 

 

$

10.2

 

 

$

31.3

 

 

$

28.2

 

Ultrasound (B)

 

 

(79.3

)

 

 

(5.0

)

 

 

(89.7

)

 

 

(19.5

)

Security and Detection (C )

 

 

2.5

 

 

 

2.4

 

 

 

7.2

 

 

 

2.4

 

Total (loss) income from operations

 

 

(64.6

)

 

 

7.6

 

 

 

(51.2

)

 

 

11.1

 

Total other income (loss), net

 

 

0.10

 

 

 

(0.9

)

 

 

(0.4

)

 

 

(4.9

)

(Loss) income before income taxes

 

$

(64.5

)

 

$

6.7

 

 

$

(51.6

)

 

$

6.2

 

 

 

 

As of

 

 

As of

 

 

 

April 30,

 

 

July 31,

 

(in millions)

 

2017

 

 

2016

 

Identifiable total assets by segment:

 

 

 

 

 

 

 

 

Medical Imaging

 

$

182.8

 

 

$

191.1

 

Ultrasound

 

 

146.8

 

 

 

152.5

 

Security and Detection

 

 

42.6

 

 

 

49.8

 

Total reportable segment assets

 

 

372.2

 

 

 

393.4

 

Corporate assets (D)

 

 

193.1

 

 

 

165.6

 

Total identifiable assets

 

$

565.3

 

 

$

559.0

 

 

(A)

Includes restructuring charges of $0.2 million and $1.1 million for three months ended April 30, 2017 and April 30, 2016, respectively and $0.4 million and $5.1 million for nine months ended April 30, 2017 and April 30, 2016.  

(B)

Includes restructuring charges of $1.8 million and $0.4 million for three months ended April 30, 2017 and April 30, 2016, respectively and $1.9 million and $1.7 million for nine months ended April 30, 2017 and April 30, 2016.

Includes contingent consideration charges of $(2.1) million and $(10.2) million related to Oncura for three and nine months ended April 30, 2017, respectively. Includes asset impairment charges of $3.1 million related to Oncura intangible assets for three and nine months ended April 30, 2017. Includes asset impairment charges of $8.1 million related to PocketSonics intangible assets for three and nine months ended April 30, 2017. Includes goodwill impairment charges of $6.7 million and $16.5 million related to Oncura reporting unit for three and nine months ended April 30, 2017. Includes goodwill impairment charges of $55.1 million related to Ultrasound reporting unit for three and nine months ended April 30, 2017. Includes charges for the BK Medical matter of $0.0 million and $10.1 million for three and nine months ended April 30, 2016 .

(C)

Includes restructuring charges of $0.1 million and $0.3 million for three months ended April 30, 2017 and April 30, 2016, respectively and $0.1 million and $1.5 million for nine months ended April 30, 2017 and April 30, 2016.  

Includes asset impairment charges of $0.0 million and $0.6 million related to Pathfinder for three and nine months ended April 30, 2017.

(D)

Includes cash and cash equivalents of $144.9 million and $97.3 million as of April 30, 2017 and July 31, 2016, respectively.